Neuro3d

PharmaceuticalsSeries CMulhouse, France

Latest round

Series C

Last raised

Jan 2005

Total raised

$59M

Investors

8

About Neuro3d

A. is a biopharmaceutical company that operates as a manufacturer of medical drugs for the treatment of psychiatric disorders.

Who invested in Neuro3d

8 investors across 3 rounds

See all investors in Neuro3d

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 3, 2005

    Amount

    $32M

    Investors

    Locked

  2. Series B

    Sep 25, 2002

    Amount

    $20M

    Investors

    Locked

  3. Series A

    Nov 1, 2000

    Amount

    $7.6M

    Investors

    Locked

Questions about Neuro3d

Who invested in Neuro3d?

Neuro3d has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Neuro3d raised?

Neuro3d has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Neuro3d last raise money?

Neuro3d's most recent round on record is a Series C, in Jan 2005.

What does Neuro3d do?

Neuro3d is a pharmaceuticals company.

Where is Neuro3d headquartered?

Neuro3d is headquartered in Mulhouse, France.

Which VCs invest in companies like Neuro3d?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Neuro3d's stage. Their profiles are linked below.

Raising like Neuro3d? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.